SHPH
Shuttle Pharmaceuticals Holdings, Inc.Company Information
- Company Name
- Shuttle Pharmaceuticals Holdings, Inc.
- CIK
- CIK0001757499
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- SHPH: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- SHPH
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-07-10
- Last sale
- 2026-07-14
- Shares purchased (TTM)
- 19,296
- Shares sold (TTM)
- 109,669
Institutional Sentiment
- As of
- 2024-03-31
- Institutional shares owned
- 38,910
- Shares outstanding
- 83,030
- Ownership
- 46.86%
Earnings Market Reaction
- Filing date
- 2026-09-24
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 1 | 0 | 2 | 5 | 5 | 2 | 0 | 1 | 1 | 3 | 4 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 0 | 2 | 1 | 3 | 5 | 5 | 2 | 0 | 2 | 4 | 6 | 7 | ||||||
| Marketable Securities Current | - | - | - | - | - | - | - | - | 2 | 3 | 3 | 3 | ||||||
| Interest Receivable Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Current | - | - | - | - | - | - | - | - | - | 0 | - | 0 | ||||||
| Deferred Costs Current | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 9 | 9 | 10 | - | - | - | - | - | - | - | - | - | ||||||
| Deferred Costs | - | - | 0 | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 23 | 12 | 10 | 4 | 6 | 5 | 3 | 1 | 3 | 5 | 6 | 7 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 3 | 2 | 1 | 1 | 1 | 1 | 1 | - | - | - | - | - | ||||||
| Interest Payable Current | - | - | - | - | - | - | 0 | - | 0 | 0 | - | - | ||||||
Liabilities Current | ||||||||||||||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | - | - | 1 | - | 1 | - | ||||||
| Liabilities Current | 3 | 8 | 8 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Derivative Liabilities Current | - | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Notes Payable Current | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
| Asset Acquisition Contingent Consideration Liability Current | - | 2 | 2 | - | - | - | - | - | - | - | - | - | ||||||
| Business Combination Contingent Consideration Liability Current | 0 | 4 | 4 | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Derivative Liabilities | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Derivative Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 4 | 8 | 8 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 71 | 52 | 49 | 45 | 45 | 41 | 35 | 32 | 30 | 30 | 29 | 19 | ||||||
| Stockholders Equity | 19 | 3 | 2 | 1 | 4 | 3 | 1 | -1 | 1 | 3 | 4 | 6 | ||||||
| Retained Earnings Accumulated Deficit | -52 | -48 | -46 | -44 | -41 | -38 | -35 | -33 | -29 | -27 | -25 | -14 | ||||||
| Liabilities And Stockholders Equity | 23 | 12 | 10 | 4 | 6 | 5 | 3 | 1 | 3 | 5 | 6 | 7 | ||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Liquidation Preference | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Authorized | - | 20 | 20 | 1 | 1 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Preferred Stock Shares Outstanding | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialShuttle Pharmaceuticals Holdings, Inc. (SHPH) — SEC Financial Statements & Analysis
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is a pharmaceutical preparations company, incorporated in DE. Shuttle Pharmaceuticals Holdings, Inc. trades on Nasdaq as: SHPH. Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-09-24. Based on that filing, Shuttle Pharmaceuticals Holdings, Inc. carries a market cap of $3.30M, a P/E ratio of -0.32x, a P/B ratio of 0.17x, an enterprise value of $3.21M, and an EV/EBITDA multiple of -0.30x. On profitability, it posts a Return on Equity (ROE) of -90.05%, a Return on Assets (ROA) of -72.47%, and a Return on Invested Capital (ROIC) of -125.52%. Per share, it reports EPS of $-10.11, diluted EPS of $-10.11, free cash flow per share of $-6.59, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -15.50% year-over-year and EPS growth of -90.63% year-over-year. On the balance sheet, it maintains a current ratio of 0.11x, a quick ratio of 0.03x, working capital of $-3.08M, a debt-to-equity ratio of 0.19x, a debt ratio of 0.16, an interest coverage ratio of -15563.85x, free cash flow of $-6.69M (TTM), and net debt of $-90.24K. Figures sourced from SEC EDGAR.
- Market Cap
- $3.30M
- P/E TTM
- -0.32x
- EPS TTM
- $-10.11
- P/B TTM
- 0.17x
- ROE TTM
- -90.05%
- ROA TTM
- -72.47%
- Debt To Equity
- 0.19x
- Free Cash Flow TTM
- $-6.69M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Shuttle Pharmaceuticals Holdings, Inc. in?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) operates in the Pharmaceutical Preparations industry.
What exchange does SHPH trade on?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) trades on the Nasdaq.
Where is Shuttle Pharmaceuticals Holdings, Inc. incorporated?
Shuttle Pharmaceuticals Holdings, Inc. is incorporated in DE.
When was Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s most recent SEC filing?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-09-24.
What is SHPH's market cap?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has a market capitalization of $3.30M as of 2026-06-30.
What is SHPH's EPS (earnings per share)?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s trailing twelve month EPS is $-10.11 as of 2026-06-30.
What is SHPH's ROE (return on equity)?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s trailing twelve month Return on Equity (ROE) is -90.05% as of 2026-06-30.
What is SHPH's ROA (return on assets)?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s trailing twelve month Return on Assets (ROA) is -72.47% as of 2026-06-30.
What is SHPH's ROIC (return on invested capital)?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s trailing twelve month Return on Invested Capital (ROIC) is -125.52% as of 2026-06-30.
What is SHPH's EV/EBITDA?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)'s trailing twelve month EV/EBITDA is -0.30x as of 2026-06-30.